520 related articles for article (PubMed ID: 7542823)
21. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
Tarján M; Tot T
Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
[TBL] [Abstract][Full Text] [Related]
22. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
23. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.
Partin AW; Mangold LA; Lamm DM; Walsh PC; Epstein JI; Pearson JD
Urology; 2001 Dec; 58(6):843-8. PubMed ID: 11744442
[TBL] [Abstract][Full Text] [Related]
24. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
Sankin A; Tareen B; Lepor H
Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
[TBL] [Abstract][Full Text] [Related]
25. [Preoperative parameters, including percent of positive biopsy cores, in predicting pathological findings after radical prostatectomy].
Inagaki T; Kohjimoto Y; Hagino K; Kuramoto T; Mori T; Kikkawa K; Iba A; Uekado Y; Shinka T
Nihon Hinyokika Gakkai Zasshi; 2007 Mar; 98(3):565-72. PubMed ID: 17419367
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic problems and prognostic factors in prostate cancer].
Tarján M
Magy Onkol; 2016 Mar; 60(1):72-7. PubMed ID: 26934354
[TBL] [Abstract][Full Text] [Related]
27. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
Tewari A; Narayan P
J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
[TBL] [Abstract][Full Text] [Related]
28. Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Tomaszewski JE; Wein A
Cancer; 2000 May; 88(9):2110-5. PubMed ID: 10813723
[TBL] [Abstract][Full Text] [Related]
29. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.
D'Amico AV; Whittington R; Schnall M; Malkowicz SB; Tomaszewski JE; Schultz D; Wein A
Cancer; 1995 May; 75(9):2368-72. PubMed ID: 7536124
[TBL] [Abstract][Full Text] [Related]
30. Preoperative serum prostate-specific antigen, clinical stage and Gleason sum as basis for predicting final pathological stage in Japanese patients with prostate cancer.
Egawa S; Koh H; Satoh T; Ohori M; Uchida T; Kuwao S; Koshiba K
Jpn J Clin Oncol; 1996 Dec; 26(6):438-44. PubMed ID: 9001349
[TBL] [Abstract][Full Text] [Related]
31. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage.
Poulakis V; Witzsch U; De Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
J Urol; 2004 Oct; 172(4 Pt 1):1306-10. PubMed ID: 15371829
[TBL] [Abstract][Full Text] [Related]
32. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
33. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Aronson WJ; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Terris MK;
Urology; 2003 Apr; 61(4):742-7. PubMed ID: 12670558
[TBL] [Abstract][Full Text] [Related]
34. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
[TBL] [Abstract][Full Text] [Related]
35. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.
Peller PA; Young DC; Marmaduke DP; Marsh WL; Badalament RA
Cancer; 1995 Jan; 75(2):530-8. PubMed ID: 7529129
[TBL] [Abstract][Full Text] [Related]
36. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Clin Oncol; 1996 Jun; 14(6):1770-7. PubMed ID: 8656245
[TBL] [Abstract][Full Text] [Related]
37. Ability of sextant biopsies to predict radical prostatectomy stage.
Wills ML; Sauvageot J; Partin AW; Gurganus R; Epstein JI
Urology; 1998 May; 51(5):759-64. PubMed ID: 9610589
[TBL] [Abstract][Full Text] [Related]
38. Prediction of extraprostatic extension in patients with clinically organ-confined prostate cancer.
Lin S; Zhang Q; Li P; Li Z; Sun Y; Shao Y; Zhang X; Fu S
Urol Int; 2014; 92(3):282-8. PubMed ID: 24280781
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
Radtke JP; Hadaschik BA; Wolf MB; Freitag MT; Schwab C; Alt C; Roth W; Duensing S; Pahernik SA; Roethke MC; Schlemmer HP; Hohenfellner M; Teber D
J Endourol; 2015 Dec; 29(12):1396-405. PubMed ID: 26154571
[TBL] [Abstract][Full Text] [Related]
40. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.
Ravery V; Boccon-Gibod LA; Dauge-Geffroy MC; Billebaud T; Delmas V; Meulemans A; Toublanc M; Boccon-Gibod L
Urology; 1994 Sep; 44(3):371-6. PubMed ID: 7521093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]